Advertisement

More articles from Signal Transduction and Functional Imaging

  • β8 Integrin in Pancreatic Cancer Cells
    Sha Jin, Wei-Chun Lee, Daniela Aust, Christian Pilarsky, Nils Cordes
    Molecular Cancer Research Oct 2019, 17 (10) 2126-2138; DOI: 10.1158/1541-7786.MCR-18-1352
  • FGFR3 Splicing in Prostate Cancer Disparities
    Jacqueline Olender, Bi-Dar Wang, Travers Ching, Lana X. Garmire, Kaitlin Garofano, Youngmi Ji, Tessa Knox, Patricia Latham, Kenneth Nguyen, Johng Rhim, Norman H. Lee
    Molecular Cancer Research Oct 2019, 17 (10) 2115-2125; DOI: 10.1158/1541-7786.MCR-19-0415
  • Mevalonate Pathway in HER2+ Breast Cancer Therapy Resistance
    Vidyalakshmi Sethunath, Huizhong Hu, Carmine De Angelis, Jamunarani Veeraraghavan, Lanfang Qin, Nicholas Wang, Lukas M. Simon, Tao Wang, Xiaoyong Fu, Agostina Nardone, Resel Pereira, Sarmistha Nanda, Obi L. Griffith, Anna Tsimelzon, Chad Shaw, Gary C. Chamness, Jorge S. Reis-Filho, Britta Weigelt, Laura M. Heiser, Susan G. Hilsenbeck, Shixia Huang, Mothaffar F. Rimawi, Joe W. Gray, C. Kent Osborne, Rachel Schiff
    Molecular Cancer Research Aug 2019, DOI: 10.1158/1541-7786.MCR-19-0756
  • KRAS in Gastric Cancer Stem–Like Cells
    Changhwan Yoon, Jacob Till, Soo-Jeong Cho, Kevin K. Chang, Jian-xian Lin, Chang-ming Huang, Sandra Ryeom, Sam S. Yoon
    Molecular Cancer Research Sep 2019, 17 (9) 1945-1957; DOI: 10.1158/1541-7786.MCR-19-0077
  • mTOR Inhibitor TAK-228 in Preclinical Bladder Cancer Models
    Anna Hernández-Prat, Alejo Rodriguez-Vida, Nuria Juanpere-Rodero, Oriol Arpi, Silvia Menéndez, Luis Soria-Jiménez, Alejandro Martínez, Natalia Iarchouk, Federico Rojo, Joan Albanell, Rachael Brake, Ana Rovira, Joaquim Bellmunt
    Molecular Cancer Research Sep 2019, 17 (9) 1931-1944; DOI: 10.1158/1541-7786.MCR-18-0923
  • SPCA2 Regulates EMT in Breast Cancer
    Donna K. Dang, Monish Ram Makena, José P. Llongueras, Hari Prasad, Myungjun Ko, Manuj Bandral, Rajini Rao
    Molecular Cancer Research Aug 2019, 17 (8) 1735-1747; DOI: 10.1158/1541-7786.MCR-19-0070
  • Targeting MEK and BET Proteins in NF1-Altered Ovarian Cancer
    Alison M. Kurimchak, Claude Shelton, Carlos Herrera-Montávez, Kelly E. Duncan, Jonathan Chernoff, James S. Duncan
    Molecular Cancer Research Aug 2019, 17 (8) 1721-1734; DOI: 10.1158/1541-7786.MCR-18-1332
  • p21 Promotes Tumor-Initiating Potential via Wnt/TCF1/Cyclin D1 Upregulation
    Outhiriaradjou Benard, Xia Qian, Huizhi Liang, Zuen Ren, Kimita Suyama, Larry Norton, Rachel B. Hazan
    Molecular Cancer Research Jul 2019, 17 (7) 1571-1581; DOI: 10.1158/1541-7786.MCR-18-1044
  • Potential Pathways Contribute to HBx-K130M/V131I-Induced HCC
    Amy P. Chiu, Barbara R. Tschida, Tung-Ting Sham, Lilian H. Lo, Branden S. Moriarity, Xiao-Xiao Li, Regina C. Lo, David E. Hinton, Dewi K. Rowlands, Chi-On Chan, Daniel K.W. Mok, David A. Largaespada, Nadia Warner, Vincent W. Keng
    Molecular Cancer Research Jul 2019, 17 (7) 1582-1593; DOI: 10.1158/1541-7786.MCR-18-1127
  • E-Cadherin Represses Anchorage-Independent Growth
    Mohit Kumar Jolly, Kathryn E. Ware, Shengnan Xu, Shivee Gilja, Samantha Shetler, Yanjun Yang, Xueyang Wang, R. Garland Austin, Daniella Runyambo, Alexander J. Hish, Suzanne Bartholf DeWitt, Jason T. George, R. Timothy Kreulen, Mary-Keara Boss, Alexander L. Lazarides, David L. Kerr, Drew G. Gerber, Dharshan Sivaraj, Andrew J. Armstrong, Mark W. Dewhirst, William C. Eward, Herbert Levine, Jason A. Somarelli
    Molecular Cancer Research Jun 2019, 17 (6) 1391-1402; DOI: 10.1158/1541-7786.MCR-18-0763

Pages